SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,909.70 -570.59
( -0.79%)

Global Indices

Nasdaq

50,945.10 -425.82
(-0.83%)

Dow Jones

7,674.56 -17.28
(-0.22%)

Hang Seng

68,949.71 2,195.99
(3.29%)

Nikkei 225

10,432.22 -173.78
(-1.64%)

Forex

USD-INR

95.97 0.01
(0.01%)

EUR-INR

108.89 -0.26
(-0.24%)

GBP-INR

126.98 -0.19
(-0.15%)

JPY-INR

0.61 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Hikal Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524735

INE475B01022

97.2386745

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HIKAL

62.95

2685.49

EPS(TTM)

Face Value()

Div & Yield %

3.46

0.28

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	1712.60	1859.80	1784.60	2023.03	1942.72	1720.44
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1712.60	1859.80	1784.60	2023.03	1942.72	1720.44
Other Income	12.30	5.00	2.50	5.41	4.89	4.98
Stock Adjustments	36.90	45.30	-19.50	14.56	35.82	-1.67
Total Income	1761.80	1910.10	1767.60	2043.00	1983.43	1723.75
EXPENDITURE :
Raw Materials	798.60	882.60	805.20	1121.59	1032.21	906.71
Power & Fuel Cost	169.80	168.10	170.20	186.91	175.46	147.83
Employee Cost	266.00	242.30	244.00	220.40	201.35	164.32
Other Manufacturing Expenses	132.40	141.50	136.50	114.60	106.37	91.27
Selling & Administrative Expenses	130.00	115.20	116.20	110.01	101.31	64.05
Miscellaneous Expenses	117.30	26.90	26.10	27.02	21.28	21.71
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1614.10	1576.60	1498.20	1780.53	1637.98	1395.88
Operating Profit	147.70	333.50	269.40	262.47	345.46	327.87
Interest	62.10	75.20	56.40	48.10	31.22	36.20
Gross Profit	85.60	258.30	213.00	214.37	314.24	291.67
Depreciation	163.80	134.40	117.60	109.01	95.67	85.25
Profit Before Tax	-78.20	123.90	95.40	105.36	218.57	206.42
Tax	-2.00	30.00	28.40	30.48	59.65	79.55
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-27.50	3.00	-2.50	-3.49	-1.59	-6.27
Reported Net Profit	-48.70	90.90	69.50	78.38	160.51	133.14
Extraordinary Items	-76.00	0.63	0.42	0.45	0.14	0.01
Adjusted Net Profit	27.30	90.27	69.08	77.93	160.37	133.13
Adjustment below Net Profit	-2.20	-1.40	-0.70	-0.60	1.19	-1.44
P & L Balance brought forward	998.60	924.00	870.00	804.60	670.03	553.12
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	12.30	14.90	14.80	12.33	27.13	14.80
P & L Balance carried down	935.40	998.60	924.00	870.05	804.60	670.03
Dividend	2.40	0.00	0.00	0.00	0.00	12.33
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	30.00	70.00	60.00	60.00	80.00	100.00
Dividend Per Share(Rs)	0.60	1.40	1.20	1.20	1.60	2.00
Earnings Per Share-Unit Curr	-3.94	7.36	5.63	6.36	13.02	10.80
Earnings Per Share(Adj)-Unit Curr	-3.94	7.36	5.63	6.36	13.02	10.80
Book Value-Unit Curr	97.09	102.20	96.16	91.93	86.62	75.70
Book Value(Adj)-Unit Curr	97.09	102.20	96.16	91.93	86.62	75.70

71,909.70 -570.59 ( -0.79%)

50,945.10 -425.82 (-0.83%)

7,674.56 -17.28 (-0.22%)

68,949.71 2,195.99 (3.29%)

10,432.22 -173.78 (-1.64%)

95.97 0.01 (0.01%)

108.89 -0.26 (-0.24%)

126.98 -0.19 (-0.15%)

0.61 0.00 (0.01%)